Table 2:

Medications used by participants during the trial

MedicationIntervention, no. (%)*
n = 226†		Control, no. (%)*
n = 247†		p value
Prophylactic agent
Prophylaxis at baseline74 (32.7)71 (28.7)
Stopped prophylaxis during trial18 (24.3)15 (21.1)0.40‡
No prophylaxis at baseline152 (67.3)176 (71.3)
Started prophylaxis during trial43 (28.3)25 (14.2)‡0.001‡
Triptans
Doses per month, mean (SE)4.80 (0.32)5.30 (0.29)0.72§

  • Note: SE = standard error.

  • ↵* Unless otherwise indicated.

  • ↵† Data not available for 7 patients in the intervention group and 10 patients in the control group.

  • ↵‡ χ2 test.

  • ↵§ t test.